1. Home
  2. INDP vs HIHO Comparison

INDP vs HIHO Comparison

Compare INDP & HIHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • HIHO
  • Stock Information
  • Founded
  • INDP 2000
  • HIHO 1990
  • Country
  • INDP United States
  • HIHO Hong Kong
  • Employees
  • INDP N/A
  • HIHO N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • HIHO Industrial Machinery/Components
  • Sector
  • INDP Health Care
  • HIHO Industrials
  • Exchange
  • INDP Nasdaq
  • HIHO Nasdaq
  • Market Cap
  • INDP 8.8M
  • HIHO 8.2M
  • IPO Year
  • INDP N/A
  • HIHO 1996
  • Fundamental
  • Price
  • INDP $0.79
  • HIHO $1.90
  • Analyst Decision
  • INDP Strong Buy
  • HIHO
  • Analyst Count
  • INDP 2
  • HIHO 0
  • Target Price
  • INDP $8.50
  • HIHO N/A
  • AVG Volume (30 Days)
  • INDP 19.4K
  • HIHO 2.7K
  • Earning Date
  • INDP 03-17-2025
  • HIHO 01-21-2025
  • Dividend Yield
  • INDP N/A
  • HIHO 6.35%
  • EPS Growth
  • INDP N/A
  • HIHO N/A
  • EPS
  • INDP N/A
  • HIHO N/A
  • Revenue
  • INDP N/A
  • HIHO $7,345,000.00
  • Revenue This Year
  • INDP N/A
  • HIHO N/A
  • Revenue Next Year
  • INDP N/A
  • HIHO N/A
  • P/E Ratio
  • INDP N/A
  • HIHO N/A
  • Revenue Growth
  • INDP N/A
  • HIHO 11.36
  • 52 Week Low
  • INDP $0.70
  • HIHO $1.70
  • 52 Week High
  • INDP $3.10
  • HIHO $2.88
  • Technical
  • Relative Strength Index (RSI)
  • INDP 48.01
  • HIHO 56.28
  • Support Level
  • INDP $0.76
  • HIHO $1.80
  • Resistance Level
  • INDP $0.86
  • HIHO $1.87
  • Average True Range (ATR)
  • INDP 0.06
  • HIHO 0.06
  • MACD
  • INDP 0.01
  • HIHO 0.00
  • Stochastic Oscillator
  • INDP 69.81
  • HIHO 64.29

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About HIHO Highway Holdings Limited

Highway Holdings Ltd is a holding company. The company is a manufacturer of metal, plastic, electric and electronic components for original equipment manufacturers (OEM) and contract manufacturers. Its operating segment includes Metal stamping and mechanical OEM and Electric OEM. The metal stamping segment focuses on the manufacturing and sale of metal parts and components. The company generates maximum revenue from the Metal stamping and mechanical OEM segment. Geographically, it derives a majority of its revenue from Europe and also has a presence in Hong Kong and China, North America, and Other Asian countries.

Share on Social Networks: